Trimebutine on the Development of Adverse Events Related to the Helicobacter Pylori Eradication Medications

Summary

Adverse events related to the eradication medication is one of the reason of lower eradication success in the H. pylori treatment. The aim of this study was to evaluate the additive effect of trimebutine for the development of adverse events related to the H. pylori eradication regimen.

Timeline

Start

2021-05-01

Primary completion

2021-06-01

Completion

2021-07-01

Drugs

Indications